In vitro pro- and antioxidant properties of estrogens

Journal of Steroid Biochemistry and Molecular Biology

Volumn 81, Issue 3, 2002, Pages 227-236

  Thibodeau, Paul A ^a   Kachadourian, Rémy ^b   Lemay, Rosalie ^a   Bisson, Martine ^a   Day, Brian J ^b   Paquette, Benoit ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Antioxidant; Breast cancer; Copper; DNA strand breaks; Estrogens; Free radicals; Hormone replacement therapy; Hydroxyestrogens; Lipid peroxidation; Pro oxidant

Indexed keywords

16ALPHA HYDROXYESTRONE; ESTRADIOL; ESTROGEN DERIVATIVE; ESTRONE; SUPEROXIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; DNA DAMAGE; DNA STRAND BREAKAGE; ESTROGEN ACTIVITY; IN VITRO STUDY; LIPID PEROXIDATION; OXIDATION; OXYGEN CONSUMPTION;

EID: 0036344912     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(02)00067-5     Document Type: Article

References (64)

1. Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy
2. Endogenous hormones as a major factor in human cancer
3. Endogenous hormones and breast cancer risk
4. A prospective study of endogenous estrogens and breast cancer in postmenopausal women
5. Estrogen metabolism and excretion in Oriental and Caucasian women
6. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
7. Increased cell division as a cause of human cancer
8. Dual role of oestrogens as hormones and pro-carcinogens: Tumour initiation by metabolic activation of oestrogens
9. Increased estrogen 16α-hydroxylase activity in women with breast and endometrial cancer
10. Covalent binding of the endogenous estrogen 16α-hydroxyestrone to estradiol receptor in human breast cancer cells: Characterization and intranuclear localization
11. Induction by estrogen metabolite 16α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells
12. 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: Role of free radicals in estrogen-induced carcinogenesis
13. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: Correlation of DNA damage by free radicals with metabolic activation to quinones
14. An electron spin resonance study of o-semiquinones formed during the enzymatic and autoxidation of catechol estrogens
15. Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters. Increased superoxide formation by redox cycling of estrogen
16. Genotoxic effects of estrogens
17. Free radical generation by redox cycling of estrogens
18. DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol
19. Characterization of DNA damage induced by 3,4-estrone-o-quinone in human cells
20. DNA damage induced by catecholestrogens in the presence of copper(II): Generation of reactive oxygen species and enhancement by NADH
21. Measurement of oxidative DNA damage by catechol estrogens and analogues in vitro
22. Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: Role of lipid peroxidation in estrogen-induced kidney carcinogenesis
23. 2-Methoxyestradiol does not inhibit superoxide dismutase
24. Current status of estrogen therapy for the menopause
25. Post-menopausal oestrogens protect against fractures of hip and distal radius: A case-control study
26. A case-control study of menopausal estrogen therapy and breast cancer
27. Postmenopausal use of estrogen and occlusion of coronary arteries
28. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
29. The inhibition of low density lipoprotein oxidation by 17β-estradiol
30. Estradiol-17β as an antioxidant: Some distinct features when compared with common fat-soluble antioxidants
31. Reduction of copper, but not iron, by human low density lipoprotein (LDL). Implications for metal ion-dependent oxidative modification of LDL
32. Measuring antioxidant efficiency of wort, malt, and hops against the 2,2′-azobis(2-amidinopropane) dihydrochloride-induced oxidation of an aqueous dispersion of linoleic acid
33. Metalloporphyrins are potent inhibitors of lipid peroxidation
34. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation
35. Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylenediaminetetraacetic acid
36. Concentration dependence of pro-oxidant and antioxidant properties of catecholestrogens
37. On the inhibitory effect of C17-sulfoconjugated catechol estrogens upon lipid peroxidation of rat liver microsomes
38. Analysis of water-soluble antioxidants by high-performance liquid chromatography with electrochemical detection
39. Copper-ion-dependent damage to the bases in DNA in the presence of hydrogen peroxide
40. Oxidation of hydroquinone by copper: Chemical mechanism and biological effects
41. DNA single strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: Hormone-induced free radical damage preceding renal malignancy
42. An o-quinone form of estrogen produces free radicals in human breast cancer cells: Correlation with DNA damage
43. DNA cleavage reaction and linoleic acid peroxidation induced by tea catechins in the presence of cupric ion
44. Antioxidant and pro-oxidant properties of estrogens
45. Antioxidant and pro-oxidant actions of estrogens: Potential physiological and clinical implications
46. B, Paquette, DNA damage induced by catecholestrogens in the presence of copper(II): Generation of reactive oxygen species and enhancement by NADH
47. Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation
48. Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: Studies using Syrian hamster embryo cells treated with 17β-estradiol and eight of its metabolites
49. Enhancement of genomic instability by 17β-estradiol in minisatellite sequences of X-ray-transformed mouse 10T1/2 cells
50. Induction by estrogens of methotrexate resistance in MCF-7 breast cancer cells
51. 4-Hydroxylation of estrogens as marker of human mammary tumors
52. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: Implications for the mechanism of uterine tumorigenesis
53. Metabolism of estradiol by human breast cancer
54. Stopped-flow investigation of antioxidant activity of estrogens in solution
55. Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro
56. Manganese-porphyrin reactions with lipids and lipoproteins
57. Mechanisms of cardioprotection by estrogens
58. Hormone replacement therapy and lipoprotein changes during early menopause
59. Evidence for the role of high density lipoproteins in mediating the antioxidant effect of estrogens
60. Thiols can either enhance or suppress DNA damage induction by catecholestrogens
61. Urinary estrogen profile determination in young Finnish vegetarian and omnivorous women
62. Glutathione
63. Metabolism of vitamin C in health and disease